Welcome to BioInsights

Céline Martin is currently a Senior Product Manager for gene therapy. She has been part of Thermo Fisher Scientific since 2017 and joined to provide bioprocess scientists with the right tools to make the world healthier. She has a Ph.D. in Bioprocessing from the French University of Lorraine, where she focused on the impact of bioreactor hydrodynamics on MSC microcarrier culture. She worked as an upstream development scientist prior to joining Thermo Fisher to optimize CHO, HEK, and ESC processes. Her current focus is on managing and developing new solutions for gene therapy manufacturing.

Rich has been a Technical Operations Executive in the biotech and the Cell and Gene therapy industry for over 30 years. He has an extensive background in commercial launches such as Enbrel, Provenge, Neulasta, and Recothrom, global supply chain strategies, and systems integration regarding personalized medicine, Chain of Custody and Chain of Identity. He has held executive positions at Iovance as Sr. Vice President of Technical Operations, Vice President of Technical Operations at ZymoGenetics and Vice President of Commercial Operations at Dendreon. In addition to on-going consulting roles, Rich has recently completed a full-time Head of Operations position at Imvax focusing on CDMO selection, build out of internal manufacturing, and establishment of an integrated solution regarding CRO, Manufacturing, and Patient Scheduling. Prior to these activities Rich has held positions at Amgen, Immunex, and Centocor.